STING1 and neoplasm: As illustrated in Figure 4I, we hypothesize that preferential mPEG unmasking in response to the weakly acidic TME can rapidly release a STING agonist and activate TriTNE to optimize synapse formation and enable local tumor cell killing while minimizing systemic toxicity.